BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22308843)

  • 1. Circulating adipocyte fatty acid-binding protein, juvenile obesity, and metabolic syndrome.
    Krzystek-Korpacka M; Patryn E; Bednarz-Misa I; Mierzchala M; Hotowy K; Czapinska E; Kustrzeba-Wojcicka I; Gamian A; Noczynska A
    J Pediatr Endocrinol Metab; 2011; 24(11-12):921-8. PubMed ID: 22308843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.
    Xu A; Wang Y; Xu JY; Stejskal D; Tam S; Zhang J; Wat NM; Wong WK; Lam KS
    Clin Chem; 2006 Mar; 52(3):405-13. PubMed ID: 16423904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight loss in prepubertal obese children is associated with a decrease in adipocyte fatty-acid-binding protein without changes in lipocalin-2: a 2-year longitudinal study.
    Corripio R; Gónzalez-Clemente JM; Pérez-Sánchez J; Näf S; Gallart L; Nosàs R; Vendrell J; Caixàs A
    Eur J Endocrinol; 2010 Dec; 163(6):887-93. PubMed ID: 20870707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between adipocyte fatty acid-binding protein levels and childhood obesity in Korean children.
    Yun KE; Kim SM; Choi KM; Park HS
    Metabolism; 2009 Jun; 58(6):798-802. PubMed ID: 19368945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of body fat reduction on plasma adipocyte fatty acid-binding protein concentration in obese patients with type 1 diabetes mellitus.
    Blaha V; Musil F; Smahelova A; Ticha A; Hyspler R; Haluzik M; Lesna J; Sobotka L
    Neuro Endocrinol Lett; 2012; 33 Suppl 2():6-12. PubMed ID: 23183502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipocyte fatty acid-binding protein in obese children before and after weight loss.
    Reinehr T; Stoffel-Wagner B; Roth CL
    Metabolism; 2007 Dec; 56(12):1735-41. PubMed ID: 17998029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
    Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
    Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum adipocyte-fatty acid binding protein discriminates patients with permanent and temporary body weight loss.
    Stejskal D; Karpisek M; Bronsky J
    J Clin Lab Anal; 2008; 22(5):380-2. PubMed ID: 18803274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome?
    Stejskal D; Karpisek M
    Eur J Clin Invest; 2006 Sep; 36(9):621-5. PubMed ID: 16919044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between adipocyte fatty acid binding protein and glucose dysregulation is closely associated with obesity and metabolic syndrome: A cohort of Han Chinese population from Yunnan plateau.
    Huang J; Chen G; Zhang Q; Wang Y; Meng Q; Xu F; Zhang X; Zou W; Mi F; Yin J
    Lipids; 2022 Jul; 57(4-5):257-264. PubMed ID: 35778866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irisin is a biomarker for metabolic syndrome in prepubertal children.
    Shim YS; Kang MJ; Yang S; Hwang IT
    Endocr J; 2018 Jan; 65(1):23-31. PubMed ID: 28904307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity.
    Haider DG; Schindler K; Bohdjalian A; Prager G; Luger A; Wolzt M; Ludvik B
    Diabetes Obes Metab; 2007 Sep; 9(5):761-3. PubMed ID: 17359244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
    Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
    Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome.
    Pahwa R; Adams-Huet B; Jialal I
    J Diabetes Complications; 2017 May; 31(5):810-813. PubMed ID: 28285929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of total adiponectin, adipocyte fatty acid binding protein and fibroblast growth factor 21 levels in individuals with metabolic syndrome.
    Novotny D; Vaverkova H; Karasek D; Lukes J; Slavik L; Malina P; Orsag J
    Physiol Res; 2014; 63(2):219-28. PubMed ID: 24397811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients.
    Koh JH; Shin YG; Nam SM; Lee MY; Chung CH; Shin JY
    Diabetes Care; 2009 Jan; 32(1):147-52. PubMed ID: 18835952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different association of circulating levels of adipocyte and epidermal fatty acid-binding proteins with metabolic syndrome and coronary atherosclerosis in Chinese adults.
    Hong J; Gu W; Zhang Y; Yan Q; Dai M; Shi J; Zhai Y; Wang W; Li X; Ning G
    Atherosclerosis; 2011 Jul; 217(1):194-200. PubMed ID: 21492859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-specific association of serum uric acid with metabolic syndrome and its components in juvenile obesity.
    Krzystek-Korpacka M; Patryn E; Kustrzeba-Wojcicka I; Chrzanowska J; Gamian A; Noczynska A
    Clin Chem Lab Med; 2011 Jan; 49(1):129-36. PubMed ID: 20961193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal fatty-acid-binding protein: a new circulating biomarker associated with cardio-metabolic risk factors and carotid atherosclerosis.
    Yeung DC; Wang Y; Xu A; Cheung SC; Wat NM; Fong DY; Fong CH; Chau MT; Sham PC; Lam KS
    Eur Heart J; 2008 Sep; 29(17):2156-63. PubMed ID: 18603624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective Evaluation of Metformin and/or Metformin Plus a New Polysaccharide Complex in Treating Severe Hyperinsulinism and Insulin Resistance in Obese Children and Adolescents with Metabolic Syndrome.
    Stagi S; Ricci F; Bianconi M; Sammarco MA; Municchi G; Toni S; Lenzi L; Verrotti A; de Martino M
    Nutrients; 2017 May; 9(5):. PubMed ID: 28531113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.